GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Ventas Inc (FRA:VEN) » Definitions » Valuation Rank

Ventas (FRA:VEN) Valuation Rank


View and export this data going back to 1997. Start your Free Trial

What is Ventas Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Ventas Valuation Rank Related Terms

Thank you for viewing the detailed overview of Ventas's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Ventas (FRA:VEN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Ventas Inc (FRA:VEN) » Definitions » Valuation Rank
Comparable Companies
DOC OHI HR SBRA CTRE MPW NHI AHR LTC CVMCA WELL XBRU:AED LSE:AGR LSE:PHP SGX:C2PU NZSE:VHP TSX:NWH.UN CHCT LSE:THRL CHTH
Traded in Other Exchanges
VTR:USA V1TA34:Brazil
Address
353 North Clark Street, Suite 3300, Chicago, IL, USA, 60654
Website
https://www.ventasreit.com
Ventas owns a diversified healthcare portfolio of nearly 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 3% of net operating income.